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Xiao-Ping Chen—A leading figure among Chinese surgeons 
 
 
Xiao-Ping Chen, male, born in Funan County of China’s 
eastern Anhui Province in 1953, was considered a reformer 
and innovator in surgery of the liver, pancreas and biliary 
system. Through four decades of research and clinical work, 
he has made remarkable achievements in regards to the 
treatment of hepato-pancreato-biliary diseases and has been 
elected as a member of the Chinese Academy of Sciences in 
2015 because of his outstanding contributions. 
Graduated from Bengbu Medical College in 1973, Chen 
continued to pursue his Master’s and Doctor’s degree in 
Surgery from Wuhan Medical College (now Tongji Medical 
College of Huazhong University of Science and Technolo-
gy) in 1982 and 1985, respectively. During that period, 
Chen was under the instruction of two renowned mentors, 
one is Zaide Wu, the other, Fazu Qiu, a pioneering surgeon 
from China and member of the Chinese Academy of Sci-
ences, both of whom have a far-reaching influence on 
Chen’s professional growth. Two of Qiu’s teachings, as 
Chen said, guide his research and clinical work all the way: 
“Be a good person, do good deeds and conduct good re-
search” and “to be a good surgeon, one must operate well, 
speak well, and write well.” In 1986–1987, Chen completed 
his postdoctoral training under the supervision of Christian 
Herfarth at Heidelberg University’s Department of Surgery. 
Later, he accepted the offer from University of Cincinnati to 
join the Department of Surgery, mainly committed to the 
research on the pathophysiology of acute liver diseases. 
Among all the extraordinary achievements Chen has 
made, modification and improvement of liver transplanta-
tion procedure is no doubt the most representative one. Liv-
er transplantation is the only treatment available to some 
patients who have developed end-stage liver disease. In 
China back to the early 1980s, due to the severe shortage of 
organ donors and the low success rate of the opera-
tion-about 10%-the treatment remained rather low nation-
wide. Driven by the urgency of saving lives, Chen did tre-
mendous experimental work and finally, in 1983, the first 
animal model for auxiliary partial orthotopic liver trans-
plantation was successfully developed. The unappalled 
procedure not only solved the problem of donor shortage,  
 
 
but also overcame the primary reason for the operation fail-
ure-the space limitation. Later, more and more clinical ap-
plications show that the procedure is safe, effective and fea-
sible. 
Moreover, several great practices and techniques have 
been brought in by Chen in the area of liver cancer. With 
around 740,000 new cases diagnosed each year in China, 
70% of the tumors in patients diagnosed with hepatocellular 
carcinoma are categorized as either large (5 to 10 cm in 
diameter) or huge (larger than 10 cm in diameter), which is 
commonly believed unable to be removed in the medical 
community. However, in the 1980s, Chen boldly made the 
hypothesis that though it remained difficult for the operation 
in clinical practice, the procedure was feasible in theory. To 
turn the theory into reality, the principal difficulty in front 
of Chen is intraoperative massive haemorrhage. Three tech-
niques to control bleeding during liver resection was in-
vented: tying up of inflow and outflow vessels without dis-
secting the hilus of the liver; occlusion of the liver’s portal 
triad and infrahepatic inferior vena cava; and implementa-
tion of the liver double-hanging manoeuvre through the 
retrohepatic avascular tunnel on the right side of the inferior 
vena cava. By employing the above techniques, intraopera-
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tive blood loss drastically reduces to around 250 mL from 
2000 mL, and accordingly, the mortality rate resulting from 
the blood loss sharply drops from 10% to 0.7%. 
In the biliary systems, however, it is well known that hi-
lar cholangiocarcinoma is the most common form of cancer 
affecting the biliary tract. Two major problems exist in the 
treatment of the disease. Firstly, the conventional choice of 
operation is hemihepatectomy with caudate lobectomy or 
extended hemihepatectomy, which involves 60% to 80% 
resection of the liver thus inevitably causing the postopera-
tive complications and high mortality rate. Chen reassessed 
the efficient and feasible dissection range dimension 
through numerous of clinical studies and finally confined it 
to the optimized 20%. The latter problem is the reconstruc-
tion of the biliary tract, especially when several bile ducts 
need to be anastomosed. Combining rich experience and 
solid theoretical foundation, Chen established an inserting 
biliary-enteric anastomosis technique, and later, improved 
this technique by leaving out the stitches of anterior wall of 
the bile ducts—a useful and critical modification for such a 
kind complex surgery. 
With so many innovations and contributions in the field 
of hepatobiliary system, Chen, nevertheless, continued to 
devote himself to the pancreas diseases. Pancreatic head 
carcinoma is the most complicated as well as the most ma-
lignant tumors among all the digestive system neoplasm. 
Surgical procedure called pancreatoduodenectomy is the 
most effective way of treatment. However, the critical 
step—pancreaticojejunostomy—of this surgery involves 
time-consuming and complex stitching. Moreover, the pro-
cedure could induce the high complication rate. Corre-
spondingly, Chen established a procedure described as in-
vaginated pancreaticojejunostomy with transpancreatic 
U-sutures. The novel and audacious innovation proved to be 
a breakthrough for pancretoduodenectomy and pancreati-
cojejunostomy for it only required 2–4 stitches yet the pan-
creatic stump automatically inserted to the intestinal lumen 
when pulling the stitches. It is no exaggeration to say that 
no other procedure ever developed can be so time-saving as 
well as effective. 
Live and learn. Chen is without doubt the proper and ex-
act interpretation of the old saying. For over 40 years of 
devotion and dedications in the career of surgeon, Chen 
broke with convention over and over again and promoted 
the hepato-pancreato-biliary surgery to a new level in Chi-
na. Great respect as well as honor has been unsparingly 
given to him from communities of surgeons around the 
world. An honorary fellow of the American Surgical Asso-
ciation since 2011, an honorary professor of the University 
of Insubria in Italy since 2013, executive council member of 
the International Hepato-Pancreato-Biliary Association 
(IHPBA) and the president of the Chinese Chapter of the 
IHPBA, he has also been appointed as the president of 
A-PHPBA since 2013. Undoubtedly, Chen is a fully- 
deserving leading figure of reform and innovation in sur-
gery of the liver, pancreas and biliary system. 
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